What is the procedure for switching a patient from Nexplanon (etonogestrel implant) to Depo (medroxyprogesterone acetate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switching from Nexplanon to Depo-Provera

Remove the Nexplanon implant and administer the first Depo-Provera injection on the same day to ensure continuous contraceptive protection without requiring backup contraception. 1

Timing and Procedure

Same-day transition is the preferred approach:

  • Schedule the Nexplanon removal and first DMPA injection for the same visit 1
  • The patient maintains immediate contraceptive coverage without any gap in protection 1
  • No backup contraception (condoms or abstinence) is needed when switching on the same day 1

Depo-Provera Administration Details

Dosing schedule:

  • Administer 150 mg depot medroxyprogesterone acetate (DMPA) by deep intramuscular injection 2
  • Repeat injections every 12 weeks (13 weeks) 1
  • The injection can be given up to 2 weeks late (15 weeks from last injection) without requiring additional contraceptive protection 1

If the patient presents more than 2 weeks late for reinjection:

  • Treat as a new start 1
  • Use backup contraception for 7 consecutive days 1
  • Consider emergency contraception if recent unprotected intercourse occurred 1

Critical Pre-Switch Counseling

Discuss expected changes in bleeding patterns:

  • Approximately 22% of Nexplanon users experience amenorrhea, while DMPA users have variable bleeding patterns that often lead to amenorrhea over time 3, 2
  • Menstrual disturbances with DMPA are common but rarely require medical intervention 2
  • Enhanced counseling about bleeding changes reduces discontinuation rates 3

Address key differences between methods:

  • DMPA requires returning every 12 weeks for injections, unlike the 3-year duration of Nexplanon 3, 2
  • DMPA is temporarily irreversible during its 3-month duration, so side effects cannot be immediately stopped 2
  • Weight gain is a more common concern with DMPA compared to Nexplanon 2
  • DMPA has no appreciable effects on blood pressure or thrombosis risk 2

Common Pitfalls to Avoid

Do not create a gap in contraceptive coverage:

  • Never remove Nexplanon without immediately starting DMPA on the same day unless the patient desires pregnancy or another method 1
  • If same-day administration is not possible, provide backup contraception for 7 days after the DMPA injection 1

Ensure proper patient education:

  • Provide accurate, easily understood information about DMPA, as the method has historically suffered from poor public image and misinformation 2
  • Counsel patients to seek advice early for menstrual disturbances rather than waiting for their next appointment 2
  • Short courses of estrogen or shorter injection intervals can improve menstrual disturbances if needed 2

Alternative: Self-Administered Subcutaneous DMPA

Consider offering self-administered DMPA-SC as an option:

  • Self-administered DMPA-SC should be made available as an additional approach to deliver injectable contraception 1
  • The same timing principles apply: remove Nexplanon and administer first DMPA-SC injection on the same day 1
  • This option improves contraceptive access and increases reproductive autonomy 1
  • Provide instruction on self-injection technique and sharps disposal 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Depo Provera. Position paper on clinical use, effectiveness and side effects.

The British journal of family planning, 1999

Guideline

Nexplanon Contraceptive Effectiveness and Duration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.